Clinical Trial: Bioequivalence Study of ADC118 Tablets in Healthy Chinese Volunteers Under Fasting Conditions

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07753902) titled 'Bioequivalence Study of ADC118 Tablets in Healthy Chinese Volunteers Under Fasting Conditions' on July 28.

Brief Summary: This clinical trial aims to evaluate the bioequivalence of a single oral dose of the test drug ADC118 tablets compared with the reference drugs (ACC017 tablets and emtricitabine/tenofovir alafenamide fumarate tablets [II]) under fasting conditions in healthy adult Chinese participants. It will also assess the safety of the test drug. The main questions it aims to answer include:

Is the rate and extent of absorption of the test drug ADC118 tablets equivalent to that of the reference drugs?

What adverse events wi...